相关实验视频

Updated: Jan 11, 2026

Conversion of Human Induced Pluripotent Stem Cells iPSCs into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors

Conversion of Human Induced Pluripotent Stem Cells iPSCs into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors

Published on: May 1, 2019

作为LXR激动剂,它可以拯救SPG3A患者特定的iPSC衍生神经元中的突触功能障碍和退行

Gitika Thakur¹, Rutuja Dhanukate¹, Yongchao Mou^1,2

¹Department of Biomedical Sciences, University of Illinois College of Medicine Rockford, Rockford, IL, 61107, USA.

Acta neuropathologica communications

|November 18, 2025

概括

遗传性性形 (HSP) 涉及轴突退化. 这项研究发现,突触功能障碍有助于SPG3A神经元退化,而LXR623治疗显示出这种神经退行性疾病的治疗潜力.

科学领域:

神经科学是一个神经科学.
遗传学是一个遗传学.
细胞生物学细胞生物学

背景情况:

遗传性性 (HSP) 是一组遗传性神经系统疾病,导致轴突退化和步行障碍.
SPG3A是一种常见的早期发病的HSP,由ATL1基因的突变引起,导致脂质缺陷和神经元退行.
在SPG3A中皮质投射神经元 (PN) 退化的精确机制和潜在的治疗点仍然不清楚.

研究的目的:

调查突触功能障碍在SPG3A神经退行症中的作用.
探索SPG3A患者衍生神经元中使用LXR激动剂准脂质代谢的治疗潜力.

主要方法:

从具有明显ATL1突变的SPG3A患者产生患者特异性诱导多能干细胞 (iPSC).
通过RNA测序将IPSC分化为皮层PN,并通过RNA测序分析基因/蛋白质表达.
利用成像来评估神经元活动和用LXR激活剂 (LXR623) 治疗的细胞.

主要成果:

SPG3A皮层PNs表现出降低的突触基因/蛋白质表达和降低的神经元活动.
LXR623治疗显著改善了SPG3A神经元中的突触蛋白水平和活性.
施用LXR623挽救了轴突退化和亡,恢复了关键的基因表达模式.

结论:

突触功能障碍在SPG3A神经元的退化中起着至关重要的作用.
通过解决脂质和突触缺陷,LXR623在减轻SPG3A中的皮质神经元退化方面显示出治疗前景.

关键词:

轴突退化是一种轴突退化.遗传性性护理症是遗传性的脂质的恒常性脂质的恒常性突触功能障碍突触功能障碍突触功能障碍这就是 iPSC 的意义.

更多相关视频

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

相关概念视频

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...